Global Isothermal Nucleic Acid Amplification Technology Market Size (2024 - 2029)

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis

The Isothermal Nucleic Acid Amplification Technology (INAAT) Market is expected to register a CAGR of 11.1% during the forecast period 2022-2027.

COVID-19 is expected to have a significant impact on the growth of the market. The COVID-19 pandemic observed isothermal methods implemented as a basic technology used for the diagnosis of SARS-CoV-2 RNA in home and clinical testing centers. Furthermore, in March 2020, Abbott received the United States Food and Drug Administration approval for the Emergency use of ID NOW COVID-19, an instrument-based, isothermal, rapid system for the qualitative finding of disease. Thus increased utilization during pandemic and product approvals and launches are expected to accelearte the growth of the market during the forecast period.

The increasing incidences of chronic diseases and an aging population, an increase in the adoption of INAAT over PCR, and a rise in demand for low-cost and effective diagnostics procedures are some of the major factors that are driving the growth of the market studied. According to the World Health Organization report in February 2022, Cancer was one of the major cause of death worldwide. The report states that Each year, approximately 400,000 children develop cancer in which cervical cancer is the most common in 23 countries. The report Published by International Agency for Research on Cancer (IARC) in December 2020 that the global cancer burden has risen to 19.3 million cases. and thus, due to the high prevalence of cancer around the world, the demand for effective therapy or treatment is increasing which is expected to drive the growth of the market.

Nucleic acid amplification has several applications in the healthcare industry starting from research to clinics. Until now, PCR has been the most widely-used amplification technology across the world. A thermal cycler is required in PCR, as various temperatures need to be maintained at different steps of the amplification process. Additionally, contaminants must be removed for effective amplification through this technology. The thermal cycler itself is costly, and sample preparation to remove contaminants from the sample makes the overall process more costly and time-consuming.

Owing to this high cost, the technique has witnessed limited adoption in developing countries, where the demand for this technology is extremely high, especially for clinical application. This high demand has led to the development of novel innovative techniques, such as isothermal nucleic acid amplification technology.

The isothermal technique, as the name suggests, is performed at a fixed temperature. This temperature can vary depending on the type of nucleic acid. The tedious task of preparing a sample is not required, as the technology can take a sample directly for amplification. Additionally, the technology is affordable, making it accessible for people belonging to different economic levels across the world. The low-cost associated with technology is likely to result in increased adoption, especially in the developing regions.

Hence, owing to the cost benefits and the use of novel technologies, INAAT market is expected to grow in the coming future.

Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Segmentation

As per the scope of the report, nucleic acid amplification technologies are used in the field of molecular biology and recombinant DNA technologies. These techniques are used as leading methods in detecting and analyzing a small number of nucleic acids. Isothermal nucleic acid amplification technology protocols are varied, and have many advantages, as it is extremely fast and does not require thermocyclers. The Isothermal Nucleic Acid Amplification Technology (INAAT) Market is segmented By Technology(Helicase-dependant Amplification(HDA), Nicking Enzyme Amplification Reaction(NEAR), Loop-mediated Isothermal Amplification(LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification(NASBA), Transcription Mediated Amplification (TMA), Single Primer Isothermal Amplification(SPIA), Other Technologies), By Product(Instruments and Reagent), By End-User (Hospital, Research laboratories, Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.